Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CLDX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

10.05

Margin Of Safety %

Put/Call OI Ratio

1.31

EPS Next Q Diff

0.1

EPS Last/This Y

-0.45

EPS This/Next Y

-0.02

Price

41.72

Target Price

58.07

Analyst Recom

1.19

Performance Q

25.18

Upside

-233.1%

Beta

0.85

Ticker: CLDX



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-14CLDX38.171.140.339168
2026-07-15CLDX38.321.140.039169
2026-07-16CLDX35.391.140.089198
2026-07-17CLDX35.341.131.009209
2026-07-20CLDX35.411.40135.007543
2026-07-21CLDX31.341.441.047677
2026-07-22CLDX34.751.341.339707
2026-07-23CLDX35.461.360.3410381
2026-07-24CLDX35.31.350.1210405
2026-07-27CLDX35.661.330.3310448
2026-07-28CLDX35.611.320.0610510
2026-07-29CLDX37.541.310.0610543
2026-07-30CLDX38.511.280.2410652
2026-07-31CLDX38.091.280.1110695
2026-08-03CLDX37.491.2910.2210657
2026-08-04CLDX39.11.310.6910753
2026-08-05CLDX41.031.330.0910700
2026-08-06CLDX40.731.321.0910754
2026-08-07CLDX41.751.310.1310823
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-14CLDX38.19-25.3-60.0-4.39
2026-07-15CLDX38.29-25.3-65.3-4.39
2026-07-16CLDX35.40-25.3-30.6-4.39
2026-07-17CLDX35.35-25.3-63.2-4.39
2026-07-20CLDX35.40-25.3-64.4-4.39
2026-07-21CLDX35.65-25.3-67.0-4.39
2026-07-22CLDX34.81-25.3-53.4-4.39
2026-07-23CLDX35.42-25.3-72.0-4.39
2026-07-24CLDX35.28-25.3-62.2-4.39
2026-07-27CLDX35.65-25.3-68.7-4.39
2026-07-28CLDX35.60-25.3-63.3-4.39
2026-07-29CLDX37.53-25.3-87.8-4.39
2026-07-30CLDX38.49-25.3-75.3-4.39
2026-07-31CLDX38.07-25.3-59.2-4.39
2026-08-03CLDX37.69-25.3-59.7-4.39
2026-08-04CLDX37.69-25.3-59.7-4.39
2026-08-05CLDX41.08-24.8-86.3-4.35
2026-08-06CLDX41.60-24.8-69.3-4.35
2026-08-07CLDX41.72-24.8-65.1-4.35
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-14CLDX0.00-0.6110.15
2026-07-15CLDX0.00-0.6110.15
2026-07-16CLDX0.00-0.6110.15
2026-07-17CLDX0.00-0.6110.15
2026-07-20CLDX0.00-0.6810.15
2026-07-21CLDX0.00-0.6810.15
2026-07-22CLDX0.00-0.6810.15
2026-07-23CLDX0.00-0.6810.15
2026-07-24CLDX0.00-0.6810.15
2026-07-27CLDX0.00-0.6510.05
2026-07-28CLDX0.00-0.6510.05
2026-07-29CLDX0.00-0.6510.05
2026-07-30CLDX0.00-0.6510.05
2026-07-31CLDX0.00-0.6510.05
2026-08-03CLDX0.00-0.1410.05
2026-08-04CLDX0.00-0.1410.05
2026-08-05CLDX0.00-0.1410.05
2026-08-06CLDX0.00-0.1410.05
2026-08-07CLDX0.00-0.1410.05
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-1.18

Avg. EPS Est. Current Quarter

-1.06

Avg. EPS Est. Next Quarter

-1.08

Insider Transactions

Institutional Transactions

-0.14

Beta

0.85

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

19

Growth Score

29

Sentiment Score

98

Actual DrawDown %

27.1

Max Drawdown 5-Year %

-73.1

Target Price

58.07

P/E

Forward P/E

PEG

P/S

3763.11

P/B

6.09

P/Free Cash Flow

EPS

-4.27

Average EPS Est. Cur. Y​

-4.35

EPS Next Y. (Est.)

-4.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-32753.58

Relative Volume

0.79

Return on Equity vs Sector %

-89.5

Return on Equity vs Industry %

-73.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

-65.1
◆ CLDX Healthcare
$41.71
📉
Swing / Pullback
Buy the dip on strong trends
43 /100
WEAK
Trend
12/20
Pullback
8/25
Volume
9/15
Valuation
8/20
TP/AR
2/10
Options
4/10
RSI
72.3
Range 1M
85.6%
Sup Dist
1.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
22 /100
WEAK
Momentum
10/25
Growth
4/30
Estimates
0/20
Inst/Vol
4/15
Options
4/10
EPS Yr
-6.5%
EPS NY
-0.9%
52W%
94.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +39.2% upside
Quality
2/30
Valuation
8/30
Growth
0/25
Stability
8/10
LT Trend
4/5
Upside
+39.2%
Quality
19
Click a card to see score breakdown Full Analysis →
CLDX — P/E HistoricalBiotechnology
Celldex Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 198
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
CLDX

Latest News

—
Caricamento notizie per CLDX…
stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today
news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance
stock history CLDX – Celldex Therapeutics, Inc. invest stock market
stock prices CLDX premarket after hours
ticker CLDX fair value insiders trading